Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Malfunctioning microRNAs Linked to Development of Lupus in Mouse Models

By LabMedica International staff writers
Posted on 16 Feb 2011
Another important regulatory role has been identified for microRNA, this time in activating molecular pathways leading to development of the severe autoimmune disorder lupus.

Lupus, which affects more than five million people worldwide, is a chronic autoimmune disease of connective tissue that causes the body's immune system to become hyperactive and attack normal, healthy tissue. More...
The processes leading to development of lupus have so far not been identified.

In an effort to rectify the situation, investigators at Virginia Polytechnic Institute and State University (Blacksburg, USA) used miRNA microarray assays and RT- (real-time)-PCR to measure miRNA expressions in splenic lymphocytes from three mouse lupus models (MRL-lpr, B6-lpr, and NZB/WF1) with different genetic backgrounds. The different models were distinguished by the age at which the animals began to develop lupus (as early as three months or as late as nine months, depending on the strain).

Results published in the December 10, 2010, online edition of the journal PLoS One revealed that despite the genetic differences among the three lupus stains, a common set of dysregulated miRNAs (miR-182-96-183 cluster, miR-31, and miR-155) was present in splenocytes that differed from the miRNAs found in age-matched control mice. The association of these miRNAs with the disease was highlighted by the observation that this miRNA expression pattern became evident in NZB/WF1 mice only at the age when lupus disease was manifested.

Given that miRNAs are conserved, with regard to both evolution and function, the observation of a common lupus disease-associated miRNA expression pattern in mouse lupus models is likely to have significant pathogenic, diagnostic, and/or therapeutic implications for human lupus.

"In the short term, we want to use our better understanding of the disease to develop a tool in the form of molecular markers for early, reliable diagnosis,” said senior author Dr. S. Ansar Ahmed, professor of immunology at Virginia Polytechnic Institute and State University. "The long-term goal is to offer entirely new therapeutic approaches, such as manipulation of lupus-related miRNA, to correct pathological conditions.”

"If we can do this in a mouse model and then to cure other animals, hopefully it can one day be done in humans,” said Dr. Ahmed. "This is long-range research but modern technology is narrowing the time it takes from mouse to human — speeding translation.”

Related Links:
Virginia Polytechnic Institute and State University



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Capillary Blood Collection Tube
IMPROMINI M3
New
Automatic Hematology Analyzer
DH-800 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Platelets sequester cfDNA during circulation (Murphy L. et al., Science, 2025; DOI: 10.1126/science.adp3971)

Platelets Could Improve Early and Minimally Invasive Detection of Cancer

Platelets are widely recognized for their role in blood clotting and scab formation, but they also play a crucial role in immune defense by detecting pathogens and recruiting immune cells.... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.